API and formulations firm Ipca Laboratories is to spend more than INR10bn to acquire a 33% holding in its fellow Indian firm Unichem Laboratories, with designs to add a further 26% stake.
Ipca Laboratories has reached a definitive agreement to acquire a 33.38% stake in its fellow Indian firm Unichem Laboratories for INR10.34bn ($126.2m) in cash, in what Ipca believes is a complementary transaction that aligns with its strategy “to enhance our portfolio in our chosen growth markets.”
At the same time, Ipca is launching an open offer of INR8.05bn to obtain a further 26% stake in Unichem,...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
